LRRK2 and Parkinson disease: Subgroup analysis of carriers of the LRRK2 mutation, a mutation in the leucine-rich repeat kinase 2 gene (known for an increased risk for sporadic PD) [61], revealed an even greater decrease of plasma caffeine level by 76% for PD LRRK2 mutation carriers compared to healthy LRRK2 carriers [62].